depression medicines

 As per available reports about 1715 journals, 20 Conferences, 15 workshops are presently dedicated exclusively to Depression medicine and about 54729 articles are being published on the current trends in Depression medicine. In terms of research annually, USA, India, Brazil, Japan, Switzerland and Canada are some of the leading countries where maximum studies related to Depression medicine are being carried out. As reported in Elevated Depression Symptoms, Antidepressant Medicine Use and Risk of Developing Diabetes during the Diabetes Prevention Program article, Depression medicine is also known as antidepressant or the medication commonly used to treat depression. There is emerging evidence that modifiable cardiovascular risk factors are also increased in patients with bipolar disorders and in those with a history of depression or taking drugs to treat depression.

OMICS International – a pioneer in organizing international conferences OMICS Group is a pioneer and leading scientific event organizer, which publishes around 300 Open Access Journals and organizes over 100 Scientific Conferences all over the globe annually with the support from various scientific associations and 20,000 editorial board members. Since its inception, OMICS Group has focused on meeting the needs of the scientific community, through strong tie-up with business and industry, while at the same time accomplishing international benchmarks and accreditation standards. OMICS Group Conferences are integrated with workshops, symposia, trade shows and world congresses by bringing together people on a single platform thereby achieving its motto of escalating and enlightening the lamp of knowledge across the world in all the areas of Science, Medicine and Technology.